tirzepatide generic date FDA confirms shortage is still over, gives compounders a grace period Trimi GLP-1 Review 2026: What

Studies show that patients with diabetes (with an average starting BMI of 33.9) who started taking the lower 1.0mg dose of semaglutide, approved for diabetes in 2017, lowered their BMI by 1.6 points in just 30 weeks

The body produces it naturally, but levels can be affected by age, stress, environmental exposure, and daily demands on the body

How PlexusDx Supports a More Personalized Approach PlexusDx Precision Peptide Genetic Test may help provide context by revealing predispositions in peptide-pathway genes (GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, MC4R rs17782313) that can support a more informed provider conversation about semaglutide candidacy and dose titration strategy

Comparing Reflux Medications Not everyone needs a daily medication like omeprazole